Long-Term Prognosis in Patients With Type 1 and 2 Diabetes Mellitus After Coronary Artery Bypass Grafting
作者: Martin J. HolzmannBjörn RathsmanBjörn EliassonJeanette KuhlAnn-Marie SvenssonThomas NyströmUlrik Sartipy
作者单位: 1Department of Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden
2Department of Internal Medicine, Karolinska Institutet, Stockholm, Sweden
3Karolinska Institutet, Department of Clinical Sciences and Education, Sachs’ Children’s Hospital, Stockholm, Sweden
4Institute of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
5University of Gothenburg, Göteborg, Sweden
6Department of Cardiovascular Medicine, Danderyds Hospital, and Department of Internal Medicine, Clinical Sciences, Karolinska Institutet, Stockholm, Sweden
7Centre of Registers in Region Västra Götaland, Göteborg, Sweden
8Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden
9Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, Stockholm, Sweden
10Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
刊名: Journal of the American College of Cardiology, 2015, Vol.65 (16), pp.1644-1652
来源数据库: Elsevier Journal
DOI: 10.1016/j.jacc.2015.02.052
关键词: isolated CABGmajor adverse coronary eventprognosisrevascularization
英文摘要: Abstract(#br)Background(#br)Patients with diabetes mellitus (DM) have an increased risk of adverse outcomes after coronary artery bypass grafting (CABG). Previous studies have reported prognosis in relation to treatment with or without insulin, and not to the type of diabetes.(#br)Objectives(#br)This study investigated long-term survival in patients with type 1 DM (T1DM) and type 2 DM (T2DM) following CABG.(#br)Methods(#br)We included all patients from the SWEDEHEART (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) register who underwent primary isolated CABG in Sweden during 2003 through 2013. We identified patients with T1DM or T2DM in the Swedish National Diabetes Register. We calculated hazard...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:14.086 (2012)

×